Parataxis Makes Power Move: Acquires Bridge Bio to Create South Korea’s Pioneer Bitcoin Treasury Firm
South Korea's crypto landscape just got a seismic shake-up. Parataxis Holdings—known for its aggressive digital asset plays—has swallowed Bridge Bio whole to birth the nation's first Bitcoin treasury firm. No more dipping toes; this is a cannonball into corporate BTC adoption.
Why this matters: While traditional finance still debates 'store of value,' crypto-native firms are building the infrastructure to make Bitcoin a balance sheet staple. Parataxis isn't waiting for regulatory permission slips—they're rewriting the playbook.
The cynical take? Another week, another firm realizing holding BTC beats praying for 0.1% APY on 'high-yield' savings accounts. South Korea's institutional crypto winter might be thawing faster than expected.
TLDR
- Parataxis to Launch South Korea’s First Bitcoin Treasury Firm via Biotech Buyout
- Bridge Bio to Rebrand as Parataxis Korea in KRW 25B Bitcoin Strategy Pivot
- Parataxis Acquires Biotech Firm to Merge Digital Assets with Public Markets
- Bitcoin Meets Biotech: Parataxis Reshapes Korean Firm for Treasury Push
- Parataxis Capital Expands BTC Strategy with South Korea’s First Public Treasury Play
Parataxis Holdings will acquire a controlling interest in Bridge Biotherapeutics to establish South Korea’s first Bitcoin Treasury firm. The deal involves a KRW 25 billion investment and includes a rebranding of the biotech firm to Parataxis Korea. This move reflects growing momentum around Bitcoin Treasury strategies in Asia’s public markets.
Parataxis Holdings Restructures Biotech Firm for Bitcoin Treasury Pivot
Parataxis Holdings, affiliated with Parataxis Capital Management, will transform Bridge Biotherapeutics for $18.5 million to focus on bitcoin Treasury and a biotech company. The acquisition gives Parataxis a controlling stake and enables public market entry for its Bitcoin Treasury strategy. The company will remain listed on the KOSDAQ, pending shareholder approval in August.
🇰🇷 Breaking: Parataxis Holdings has secured South Korea's Bridge Biotherapeutics for $18.5M, with plans to establish a Bitcoin treasury platform supported by institutional backing in the Korean public markets. pic.twitter.com/blJ2Nv1QCo
— crypto Jessica (@CryptoJessXBT) June 20, 2025
Parataxis Korea, will integrate digital asset exposure into its balance sheet while maintaining its therapeutic programs. Edward Chin, CEO of Parataxis Holdings, will join the board, and Andrew Kim will assume the CEO role. Bridge Bio’s co-founder James Jungkue Lee will continue to manage the biotech division and remain on the board.
The transition aligns with Parataxis Capital’s strategy to expand Bitcoin Treasury adoption through regulated, publicly listed entities. The firm has observed growing demand from institutions for structured Bitcoin Treasury exposure. The restructured company will serve as a South Korean platform for long-term BTC accumulation.
Strategic Board Reshuffle and Corporate Rebranding
The firm will appoint Parataxis Capital executives to leadership roles, reinforcing its Bitcoin Treasury focus. Edward Chin brings institutional digital asset expertise, while Andrew Kim will lead the strategic execution. Their appointment signals the company’s intent to anchor Bitcoin Treasury practices within the KOSDAQ ecosystem.
The upcoming name change to Parataxis Korea signals a shift from biotech specialization to digital asset strategy integration. The entity will operate under South Korea’s regulatory framework, which continues to mature. This dual-model approach blends biotech innovation with Bitcoin Treasury management.
Shin & Kim LLC and Deloitte are advising on the legal and financial structuring of the deal. The transaction remains subject to standard regulatory and shareholder approvals. A shareholder meeting is scheduled in August to finalize the acquisition process.
Institutional Focus on Bitcoin Treasury in South Korea
Parataxis Holdings believes South Korea represents a critical market for institutional-grade Bitcoin Treasury growth. The country’s robust capital markets and increasing crypto regulation provide a strong environment for such strategies. The firm’s expansion into Asia follows models observed in the US and Japan.
The MOVE marks the country’s first Bitcoin Treasury platform with backing from a digital asset-focused investment firm. With BTC’s limited supply and global adoption trajectory, Parataxis aims to offer exposure through a compliant and scalable vehicle. This strategy intends to bring BTC to corporate treasuries via trusted public structures.
